Bodal Chemicals Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹490Cr
- +10.6% YoY
- +2.1% QoQ
- Net profit
- ₹0Cr
- Q3 FY25: ₹5 Cr
- Margin
- 4.5%
- −5.5 pp YoY
- −0.3 pp QoQ
Guidance rank: #34 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Bodal Chemicals Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Consolidated revenue for Q3 FY26: Rs. 5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. 4,453.7 Mn). EBITDA (Consolidated, Q3 FY26): Rs. 371.3 million, down 20.0% YoY (Page 10).
From Bodal Chemicals Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Consolidated revenue for Q3 FY26: Rs. 5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. 4,453.7 Mn).
- Standalone revenue for Q3 FY26: Rs. 4,953.1 Mn, up 13.5% YoY (Q3 FY25: Rs. 4,362.1 Mn).
- Product-wise Q3 FY26 revenue and YoY growth:
- Dye Intermediates: Rs. 1,826 Mn, +2% YoY quarterly.
- Dyestuff: Rs. 1,315 Mn, +15% YoY quarterly.
- Basic Chemicals: Rs. 247 Mn, -15% YoY quarterly (due to annual maintenance shutdown).
2 more points from Bodal Chemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The presentation mentions a "New greenfield expansion" as part of the company's "Way Forward" strategy (Page 27).
- This expansion is aligned with capacity ramp-up goals and ongoing internal efficiencies (Page 27).
- The presentation also refers to capacity ramp-up and strengthening market leadership as priorities.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Bodal Chemicals Ltd said on order book & pipeline — free account, 30 seconds.
Bodal Chemicals Ltd — Quarterly revenue & net profit
Bodal Chemicals Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 490 | 443 | +10.6% | 480 | +2.1% |
| Operating profit (EBITDA) | 22 | 44 | -50% | 23 | -4.3% |
| Operating margin | 4.5% | 10% | -5.5 pp | 4.8% | -0.3 pp |
| Profit before tax | 0 | 8 | -100% | 6 | -100% |
| Net profit (PAT) | 0 | 5 | -100% | 6 | -100% |
| EPS (₹) | 0.02 | 0.43 | -95.3% | 0.48 | -95.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹863 Cr, net profit ₹81 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bodal Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bodal Chemicals Ltd Q3 FY26 results?
Consolidated revenue for Q3 FY26: Rs. 5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. 4,453.7 Mn). EBITDA (Consolidated, Q3 FY26): Rs. 371.3 million, down 20.0% YoY (Page 10).
What is Bodal Chemicals Ltd share price analysis?
Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹2,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bodal Chemicals Ltd planning capital expenditure?
The presentation mentions a "New greenfield expansion" as part of the company's "Way Forward" strategy (Page 27).
Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
